B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ODC1

MOLECULAR TARGET

ornithine decarboxylase 1

UniProt: P11926NCBI Gene: 49533 compounds

ODC1 (ornithine decarboxylase 1) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ODC1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Spermine1.102
2Eflornithine0.691
3Vincristine0.691

About ODC1 as a Drug Target

ODC1 (ornithine decarboxylase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented ODC1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ODC1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.